PubMed Health⌕ Search

Biomedical subjects

Edward D Sturman

Publications and source records attributed to Edward D Sturman.

3 recordsLinked to original sources

The capacity to consent to treatment and research: a review of standardized assessment tools.

The use of standardized tools for the assessment of competency is vital, given that informal assessments performed by physicians are idiosyncratic and unreliable []. A number of instruments have been developed for this purpose, which are outlined in the following review. For the most part, these tools rest on a definition of competency put forward by Appelbaum and Roth [Appelbaum, P. S., & Roth, L. H. (1982). Competency to consent to research. A psychiatric overview. Archives of General Psychiatry, 39, 951-958], which incorporates various legal standards. Therefore, the present review will summarize current thinking on competence as well as the strengths, weaknesses, and psychometric properties of existing measures. As competency assessment will be more or less necessary depending on the patient population, another goal of the paper was to assemble the major findings pertaining to patient groups that have impairments in capacity. Although competency varies between and within diagnostic groups, empirical studies consistently demonstrate increased risk for some populations, and clinicians or researchers should be aware of this information. As such, this review may be useful as an initial source for interested researchers or clinicians.

Comprehension↗

Self-criticism and major depression: an evolutionary perspective.

OBJECTIVES: This study sought to incorporate the personality style of self-criticism within an evolutionary framework to help explain its relationship to major depression. It was expected that self-critics would engage in poor social comparisons and have greater feelings of internal entrapment, which are both processes related to depression by evolutionary thinkers. DESIGN: A cross-sectional design was employed such that participants were first interviewed and then completed several questionnaires. METHODS: The sample consisted of 146 graduate students who had experienced at least one prior episode of major depression, which was confirmed using the Structured Clinical Interview for DSM-IV (SCID). Participants were subsequently administered the Center for epidemiological studies depression scale (CESD), Depressive Experiences Questionnaire (DEQ), Social comparison rating scale (SCRS), and Entrapment scale (ES). RESULTS: Regression analyses revealed that self-criticism significantly predicted internal entrapment and social comparison when controlling for mood and for levels of dependency. Subsequent Structural Equation Modelling (SEM) revealed that a factor of self-reported entrapment and social comparison mediated the effect of self-criticism on the number of previous episodes of depression. CONCLUSION: These findings suggest that part of the reason self-critics are vulnerable to clinical episodes of depression lies in their subjective experience of entrapment and in their negative social comparisons.

Attitude↗

Toward the development of a Mood Disorders Insight Scale: modification of Birchwood's Psychosis Insight Scale.

BACKGROUND: Insight has been defined as: (1) recognition of symptomatology, (2) the ability to attribute symptoms to a mental health disorder, and (3) complying with treatment. Insight is related to medication compliance, course of illness and outcome. Current instruments for measuring insight are limited to those that have been validated primarily in hospitalized patients with psychosis. Our objectives were to develop a reliable and valid self-report scale for use in outpatients or inpatients with mood disorders. Toward this end we made extensive revisions of the Birchwood et al. Insight Scale for Psychosis. METHODS: The scale was developed by modifying items from a previous self-report scale. Specifically, assumptions of hospitalizations, psychosis, and current symptomatology were removed and items related to mood state were added. The scale was included in a battery of measures completed by outpatients and inpatients participating in a study of mood stabilizer medications. RESULTS: Subjects (n=101, 66.3% female, median age 44 years) took approximately 2-3 min each to complete the scale. Overall scores were high (Mean=10.3 out of 12). Reliability was determined using test-retests (r=0.75, n=45). Validity testing was based mainly on clinician ratings (r=0.49, n=69). CONCLUSION: The new scale shows promise as a quick method for assessing insight in patients with mood disorders.

Adult↗